End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,299 INR | -0.45% | +1.18% | +32.94% |
Apr. 22 | Epigral's Consolidated Profit Climbs in Fiscal Q4; Shares Up 4% | MT |
Apr. 22 | Epigral Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024 | CI |
Sales 2022 | 15.51B 186M | Sales 2023 | 21.88B 263M | Capitalization | 39.21B 471M |
---|---|---|---|---|---|
Net income 2022 | 2.53B 30.37M | Net income 2023 | 3.53B 42.44M | EV / Sales 2022 | 3.23 x |
Net Debt 2022 | 9.68B 116M | Net Debt 2023 | 8.65B 104M | EV / Sales 2023 | 2.19 x |
P/E ratio 2022 |
16
x | P/E ratio 2023 |
11.1
x | Employees | 936 |
Yield 2022 * |
-
| Yield 2023 |
0.53% | Free-Float | 28.48% |
1 day | +2.50% | ||
1 week | +1.64% | ||
Current month | -1.49% | ||
1 month | -6.73% | ||
3 months | +4.57% | ||
6 months | +44.63% | ||
Current year | +33.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 39 | 17-05-17 | |
Director of Finance/CFO | - | 14-05-06 | |
Chairman | 41 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Chairman | 41 | 17-03-31 | |
Director/Board Member | 37 | 16-05-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.57% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 1,299 | -0.45% | 45 269 |
24-05-22 | 1,305 | +2.50% | 85,844 |
24-05-21 | 1,273 | -0.64% | 28,488 |
24-05-18 | 1,281 | +0.54% | 10,837 |
24-05-17 | 1,274 | -1.02% | 17,702 |
End-of-day quote NSE India S.E., May 21, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.54% | 651M | |
+3.17% | 104B | |
-8.02% | 62.39B | |
+72.86% | 48.95B | |
+18.82% | 39.58B | |
+3.10% | 32.08B | |
+11.94% | 20.22B | |
+13.00% | 16.86B | |
+16.25% | 14.88B | |
+2.22% | 13.99B |
- Stock Market
- Equities
- EPIGRAL Stock